ArticleProceedings of the National Academy of Sciences of the United States of America2014

Genetic variation associated with euphorigenic effects of d-amphetamine is associated with diminished risk for schizophrenia and attention deficit hyperactivity disorder.

Amy B Hart et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.